IMAGENEBIO INCORPORATED (IMA)

IMI (LON:IMI) reported a strong first-half performance for 2026, with organic revenue rising 5% and organic adjusted operating profit increasing 8%, as growth across its Automation, Life Technology and Transport platforms supported higher earnings and cash generation.

Arm Holdings Plc shares jumped after the company showed signs of fast growth in its data-center business, signaling its push into the hot segment is bearing fruit.

First Majestic Silver Corp. reports second-quarter results before the market opens Thursday, with the stock declining 7.0% over the past week as investors brace for earnings that analysts expect to decline sequentially despite production gains.

CEO Kristin Yarema converted 38,376 RSUs into ImageneBio common stock and reclassified 115,129 unvested RSUs as common stock holdings, with no purchase or sale transactions reported.

Johnson & Johnson (JNJ) has become a talking point after presenting new IMAAVY data for generalized myasthenia gravis at the European Academy of Neurology Congress, giving investors fresh information on its autoimmune portfolio. See our latest analysis for Johnson & Johnson.